TARRYTOWN, N.Y., July 8, 2019 /PRNewswire/ -- Regeneron
Pharmaceuticals, Inc. (NASDAQ: REGN) today
announced that it will report its second quarter 2019 financial and
operating results on Tuesday, August 6,
2019, before the U.S. financial markets open. The
Company will host a conference call and simultaneous webcast at
8:30 AM Eastern Time that day.
Conference Call Information
To access this call, dial
(800) 708-4540 (U.S.) or (847) 619-6397 (International). A
link to the webcast may be accessed from the 'Investors and Media'
page of Regeneron's website at
http://investor.regeneron.com/events.cfm. A replay of the
conference call and webcast will be archived on the Company's
website and will be available for 30 days.
About Regeneron Pharmaceuticals, Inc.
Regeneron (NASDAQ: REGN) is a leading biotechnology company that
invents life-transforming medicines for people with serious
diseases. Founded and led for 30 years by physician-scientists, our
unique ability to repeatedly and consistently translate science
into medicine has led to seven FDA-approved treatments and numerous
product candidates in development, all of which were homegrown in
our laboratories. Our medicines and pipeline are designed to help
patients with eye diseases, allergic and inflammatory diseases,
cancer, cardiovascular and metabolic diseases, neuromuscular
diseases, infectious diseases and rare diseases.
Regeneron is accelerating and improving the traditional drug
development process through our
proprietary VelociSuite® technologies,
such as VelocImmune® which produces
optimized fully-human antibodies, and ambitious research
initiatives such as the Regeneron Genetics Center, which is
conducting one of the largest genetics sequencing efforts in the
world.
For additional information about the company, please visit
www.regeneron.com or follow @Regeneron on Twitter.
Contact
Information:
|
|
|
|
Investor
Relations
|
Corporate
Communications
|
Justin
Holko
|
Hala Mirza
|
914.847.7786
|
914.847.3422
|
justin.holko@regeneron.com
|
hala.mirza@regeneron.com
|
View original
content:http://www.prnewswire.com/news-releases/regeneron-to-report-second-quarter-2019-financial-and-operating-results-and-host-conference-call-and-webcast-on-august-6-2019-300879907.html
SOURCE Regeneron Pharmaceuticals, Inc.